Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 28, 2477-2483, December 1, 1968]
© 1968 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaage, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaage, J.

Nonvirus-associated Antigens in Virus-induced Mouse Mammary Tumors1

Jan Vaage

Cancer Research Genetics Laboratory and Department of Bacteriology and Immunology, University of California, Berkeley, California 94720

Common, cross-reacting virus-associated tumor antigens have been demonstrated by many workers in most virus-induced experimental tumor systems, including mammary tumors induced by the mouse mammary tumor virus (MTV). By the use of mice neonatally infected with the MTV and therefore immunologically tolerant of this virus and its associated antigens, other antigens have now been detected in MTV-induced tumors which do not cross-react and which, accordingly, are probably not related directly to the inducing virus.

The immunogenicity of 23 spontaneous mouse mammary carcinomas was tested in MTV-infected C3H hosts. The immunization procedure consisted of subcutaneous implantation of living tumor tissue. The challenge was with suspensions of living tumor cells at the time of removal of the immunizing grafts. Immunity was manifested by rejection of the challenge implants by a high proportion of the presensitized hosts. Of the 23 tumors, 5 were found to induce high resistance to challenge in repeated tests. It is concluded that nonvirusassociated antigens are found in some C3H mammary carcinomas.

Histologic studies showed that presensitization resulted in lymphocytic invasion of challenge implants of tumor tissue.

Immunity to tumor-cell implants was adoptively transferred to C3H recipients with lymphocytes from sensitized C3Hf donors.

Four of the immunogenic tumors were tested for cross-immunization in C3H mice. In one test reciprocal cross-reactivity was found between two tumors. In 3 tests involving the remaining two and one of the former tumors, no cross-reactivity was detected. All 4 tumors cross-reacted in MTV-free C3Hf mice.

These findings, together with other evidence, show that mouse mammary tumors contain a common component which is immunogenic in the MTV-free C3Hf mice but not in the MTV-infected C3H mice. In addition, some tumors contain tumor-specific antigens which are unrelated to the MTV and which make them immunogenic in the MTV-infected C3H mice.

1 This work was supported by Research Grant E-344 from the American Cancer Society, Inc; Grants CA-04388, CA-05045, and CA-08357 from the National Cancer Institute, NIH, USPHS, and by Cancer Research Funds of the University of California.

Received 4/ 8/68. Accepted 8/26/68.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1968 by the American Association for Cancer Research.